ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2025

Abstract Number: 0928

Radiolabelled anti-citrullinated histone antibody CIT-013 as a tool to visualize NET rich inflamed joints in a collagen induced arthritic mouse model

Annemarie Kip1, Daphne Dorst2, Birgitte Walgreen2, Monique Helsen2, Eric meldrum1, Renato Chirivi1 and Marije Koenders2, 1Citryll BV, Oss, Netherlands, 2RadboudUMC, Nijmegen, Netherlands

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2025

Keywords: citrullination, Imaging, innate immunity, neutrophils, rheumatoid arthritis

Session Information

Date: Monday, October 27, 2025

Title: (0916–0933) Innate Immunity Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Neutrophil Extracellular Traps (NETs) contribute to the pathophysiology of multiple immune-mediated inflammatory diseases including Rheumatoid Arthritis (RA), and may be promising therapeutic targets. The first-in-class therapeutic anti-citrullinated histone antibody CIT-013 binds citrullinated histones H2A and H4 in NETs and has demonstrated efficacy in models of NET-mediated inflammation by inhibiting de novo NET formation and by enhancing clearance of existing NETs by Fc receptor-mediated phagocytosis (Chirivi et al 2021; van der Linden et al 2024).In this study, we describe the use of a NET targeting antibody as an in vivo radiotracer to detect and visualize NETs in inflamed tissues.

Methods: Mice with collagen induced arthritic (CIA) mice with no, mild, moderate and established disease (n=10/group) were intravenously injected with indium-111 labeled mouse anti-citrullinated histone antibody (mACHA). Twenty-four hours after injection, whole body Single Photon Emission Computed Tomographic (SPECT) imaging was performed on selected animals. For all animals, tissue distribution of the radiotracer was quantified ex vivo by measuring gamma radiation.

Results: In CIA mice, indium-111 labeled mACHA distributes to inflamed joints and can be detected in animals with mild inflammation with increasing accumulation of the radiotracer in the fore and hind paws correlating with higher arthritis severity. Furthermore, the radiotracer enables a highly sensitive detection of inflammation in joints not apparently inflamed upon visual inspection, such as the knee.

Conclusion: mACHA can be used as a radiotracer to visualize NETs in sites of inflammation. This proof of principle imaging study enables a human whole body PET CT imaging clinical study in RA and hidradenitis suppurativa patients during 2025. This clinical study will lead to further insights in CIT-013’s distribution, target engagement and mechanism of action in patients with immune mediated inflammatory diseases.


Disclosures: A. Kip: Citryll BV, 3, 5, 11; D. Dorst: Citryll, 12, Contract research; B. Walgreen: None; M. Helsen: None; E. meldrum: Citryll BV, 3, 3, 5, 11, 11; R. Chirivi: Citryll BV, 3, 5, 8, 10, 11; M. Koenders: BIRR, 7, Contura, 7, Eli Lilly, 5, Genmab, 7, Lemba Therapeutics, 7.

To cite this abstract in AMA style:

Kip A, Dorst D, Walgreen B, Helsen M, meldrum E, Chirivi R, Koenders M. Radiolabelled anti-citrullinated histone antibody CIT-013 as a tool to visualize NET rich inflamed joints in a collagen induced arthritic mouse model [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/radiolabelled-anti-citrullinated-histone-antibody-cit-013-as-a-tool-to-visualize-net-rich-inflamed-joints-in-a-collagen-induced-arthritic-mouse-model/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/radiolabelled-anti-citrullinated-histone-antibody-cit-013-as-a-tool-to-visualize-net-rich-inflamed-joints-in-a-collagen-induced-arthritic-mouse-model/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology